IP Library Patent Application 15638367
Patent Application
App. No. 15/638,367

REDUCING REFLUX WHILE SLEEPING BY STIMULATING SALIVA WITH ADHERING TROCHES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/638,367
Abstract

A method of reducing reflux from a stomach toward a mouth while sleeping in a person in need thereof by providing to the person an adhering, bilayer troche, comprising a first layer comprising an adhesive powder, and a second layer comprising a substrate that slowly dissolves or erodes in saliva and an ingredient to be released, wherein the ingredient stimulates saliva production in the mouth; and instructing the person to adhere one or more troches in their mouth before going to sleep, thereby causing frequent swallowing of stimulated saliva while sleeping resulting in reduced reflux from the stomach.

Claims (37)

1 . A method of reducing reflux from a stomach toward a mouth while sleeping in a person in need thereof comprising:

a. providing to the person an adhering, bilayer troche, the troche comprising:

i. a first layer comprising an adhesive that adheres in a human mouth, and

ii. a second layer comprising a substrate that slowly dissolves or erodes in saliva and an ingredient to be released, wherein the ingredient stimulates saliva production in the mouth; and

b. instructing the person to adhere in their mouth before going to sleep one or more of the troches, thereby causing frequent swallowing of stimulated saliva while sleeping resulting in reduced reflux from the stomach.

2 . The method of claim 1 where the ingredient that stimulates saliva production comprises flavor molecules.

3 . The method of claim 2 wherein the flavor molecules comprise a sweet polyol.

4 . The method of claim 3 wherein the sweet polyol molecules are selected from the group consisting of xylitol, sorbitol, maltitol, erythritol and mannitol.

5 . The method of claim 2 , wherein the flavor molecules comprise a synthetic sweetener.

6 . The method of claim 5 , wherein the synthetic sweetener molecules are selected from the group consisting of sucralose, neotame, aspartame, acesulfame potassium and saccharin.

7 . The method of claim 2 , wherein the flavor molecules comprise stevia.

8 . The method of claim 1 , wherein the troche is from about 5 mm to about 18 mm in each of two dimensions.

9 . The method of claim 1 , wherein the person is instructed to adhere the troche to an outside of a molar or gum adjoining the outside of the molar.

10 . A method of reducing reflux from a stomach toward a mouth while sleeping comprising:

adhering in the mouth before going to sleep a slowly dissolving, adhering, bilayer troche that dissolves while sleeping and releases an ingredient that stimulates saliva production while sleeping, thereby causing frequent swallowing of stimulated saliva resulting in reduced reflux from the stomach,

wherein the troche comprises

i. a first layer comprising an adhesive that adheres in a human mouth, and

ii. a second layer comprising a substrate that slowly dissolves or erodes in saliva and an ingredient to be released, wherein the ingredient stimulates saliva production in the mouth.

11 . The method of claim 10 , wherein the ingredient comprise flavor molecules.

12 . The method of claim 11 , wherein the flavor molecules comprise a sweet polyol.

13 . The method of claim 12 , wherein the sweet polyol molecules are selected from the group consisting of xylitol, sorbitol, maltitol, erythritol and mannitol.

14 . The method of claim 11 , wherein the flavor molecules comprise a synthetic sweetener.

15 . The method of claim 14 , wherein the synthetic sweetener molecules are selected from the group consisting of sucralose, neotame, aspartame, acesulfame potassium and saccharin.

16 . The method of claim 11 , wherein the flavor molecules comprise stevia.

17 . The method of claim 10 , wherein the troche is from about 5 mm to about 18 mm in each of two dimensions.

18 . The method of claim 10 , wherein the adhering troche is adhered to an outside of a molar or gums adjoining the outside of the molar.

19 . A kit, comprising:

(a) a bilayer, adhering troche, wherein the troche comprises

i. a first layer comprising an adhesive that adheres in a human mouth, and

ii. a second layer comprising a substrate that slowly dissolves or erodes in saliva and an ingredient to be released, wherein the ingredient stimulates saliva production in the mouth thereby causing frequent swallowing of stimulated saliva resulting in reduced reflux from the stomach; and

(b) instructions to adhere one or more of the troches in the mouth before sleeping.

20 . (canceled)

21 . (canceled)

22 . The kit of claim 19 , wherein the ingredient comprises flavor molecules.

23 . The kit of claim 22 , wherein the flavor molecules comprise a sweet polyol selected from the group consisting of xylitol, sorbitol, maltitol, erythritol and mannitol.

24 . The kit of claim 22 , wherein the flavor molecules comprise a synthetic sweetener selected from the group consisting of sucralose, neotame, aspartame, acesulfame potassium and saccharin.

25 . The kit of claim 22 , wherein the flavor molecules comprise stevia.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 3, 2024
From: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (AS SUCCESSOR IN INTEREST TO U.S. BANK NATIONAL ASSOCIATION), AS ADMINISTRATIVE AGENT
To: QUEST PRODUCTS, LLC; ORAHEALTH, LLC
Reel/Frame 066628/0917 →
SECURITY INTEREST Recorded Jun 22, 2020
From: QUEST PRODUCTS, LLC; ORAHEALTH, LLC
To: U.S. BANK NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 053005/0089 →
RELEASE OF SECURITY INTEREST Recorded Jun 19, 2020
From: FIFTH THIRD BANK, NATIONAL ASSOCIATION (SUCCESSOR IN INTEREST TO MB FINANCIAL BANK, N.A.), AS ADMINISTRATIVE AGENT
To: ORAHEALTH, LLC
Reel/Frame 052992/0965 →
SECURITY INTEREST Recorded Jan 11, 2019
From: ORAHEALTH, LLC
To: MB FINANCIAL BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 047964/0242 →